| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.00B | 19.66B | 10.88B | 10.64B | 8.88B | 7.83B |
| Gross Profit | 3.54B | 2.15B | 4.21B | 4.66B | 2.77B | 2.35B |
| EBITDA | 3.43B | -186.20M | 471.19M | 3.44B | 3.10B | 2.64B |
| Net Income | -1.80B | -1.65B | -1.73B | 763.51M | -181.40M | -499.03M |
Balance Sheet | ||||||
| Total Assets | 108.72B | 100.48B | 109.59B | 111.16B | 112.89B | 119.25B |
| Cash, Cash Equivalents and Short-Term Investments | 7.20B | 9.67B | 7.35B | 6.52B | 6.86B | 6.85B |
| Total Debt | 31.89B | 30.92B | 32.38B | 34.60B | 33.21B | 33.39B |
| Total Liabilities | 44.15B | 37.65B | 43.17B | 40.72B | 41.71B | 42.64B |
| Stockholders Equity | 53.23B | 52.09B | 54.09B | 56.78B | 56.82B | 61.45B |
Cash Flow | ||||||
| Free Cash Flow | 4.69B | 7.03B | 5.09B | 1.78B | 1.45B | 991.13M |
| Operating Cash Flow | 5.26B | 7.56B | 5.64B | 2.20B | 1.90B | 1.81B |
| Investing Cash Flow | -12.33M | -1.02B | 595.35M | -774.13M | -918.63M | 651.37M |
| Financing Cash Flow | -5.26B | -4.63B | -4.97B | -1.64B | -1.67B | -4.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$139.82B | 24.10 | 1.76% | 6.20% | -19.91% | -6.92% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$21.06B | 7.71 | 1.39% | 5.62% | -9.78% | -29.50% | |
59 Neutral | HK$12.49B | -6.82 | -3.14% | 5.93% | 1.37% | -157.43% | |
49 Neutral | HK$1.72B | -3.88 | -1.67% | ― | -21.25% | 24.06% | |
40 Underperform | HK$20.01B | -1.70 | -9.54% | ― | -40.92% | -42.67% |